Welcome to London Private Ultrasound, where your health and well-being are our utmost priority. Conveniently located in the heart of Central London, within the prestigious Welbeck Hospital, we offer a comprehensive range of advanced ultrasound services tailored to meet your needs.

At London Private Ultrasound, we understand the importance of accurate and timely diagnoses. That’s why we have expanded our services to include cutting-edge techniques such as elastography and fibroscan. With these innovative technologies, we can provide you with even more precise and detailed information about your health, ensuring a comprehensive assessment of your condition.

Liver elastography scans are particularly beneficial for individuals who have liver diseases or conditions that may affect the health of their liver. Here are some examples of who might benefit from a liver elastography scan:

Patients with Chronic Liver Disease: Liver elastography is commonly used in patients with chronic liver diseases such as hepatitis B or C, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, or autoimmune liver diseases. It helps in assessing the degree of liver fibrosis, which is crucial for disease staging, monitoring disease progression, and determining appropriate treatment strategies.

Individuals at Risk of Liver Fibrosis: People who have risk factors for liver fibrosis, such as obesity, diabetes, excessive alcohol consumption, or a history of liver damage, may benefit from liver elastography. It allows for the early detection of fibrosis, enabling timely interventions to prevent further liver damage.

Liver Transplant Recipients: Liver elastography can be useful in monitoring the health of transplanted livers. It helps assess post-transplant liver fibrosis, detect complications, and guide post-operative management.

The benefits of liver elastography scans include:

Non-Invasiveness: Liver elastography is a non-invasive technique that does not require a biopsy or any surgical intervention. It provides valuable information about liver fibrosis without the need for an invasive procedure.

Early Detection and Staging: Liver elastography can detect fibrosis at an early stage, allowing for timely intervention and appropriate management. It also helps in staging the severity of fibrosis, aiding in treatment decisions and prognosis assessment.

Monitoring Disease Progression: Regular liver elastography scans can track changes in liver fibrosis over time. This helps in monitoring disease progression and evaluating the effectiveness of treatment interventions.

Reduced Need for Biopsy: Liver elastography can potentially reduce the need for liver biopsies, which are invasive and carry some risks. By providing non-invasive information about liver fibrosis, it can help healthcare providers make treatment decisions without the need for a biopsy in some cases.

Overall, liver elastography scans offer a non-invasive and valuable method for assessing liver fibrosis. They provide essential information for diagnosing liver diseases, staging fibrosis severity, monitoring disease progression, and guiding treatment decisions.